Clark Eliana 4
4 · Intellia Therapeutics, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Award
Stock Option (right to buy)
2025-03-01+45,714→ 45,714 totalExercise: $10.09Exp: 2035-02-28→ Common Stock (45,714 underlying) - Award
Common Stock
2025-03-01+32,000→ 96,048 total - Sale
Common Stock
2025-03-04$8.99/sh−679$6,104→ 95,369 total
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2025, and does not represent a volitional trade by the Reporting Person.
- [F3]This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.